Il Minn, Ph.D.

Affiliations: 
2008 Pennsylvania State University, State College, PA, United States 
Area:
Cell Biology
Google:
"Il Minn"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Wendy Hanna-Rose grad student 2008 Penn State
 (Centrosome attachment to the nucleus requires the SUN-1 mediated localization of ZYG-12 to the outer membrane of the nuclear envelope in Caenorhabditis elegans embryos.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Boinapally S, Lisok A, Lofland G, et al. (2022) Hetero-bivalent agents targeting FAP and PSMA. European Journal of Nuclear Medicine and Molecular Imaging
Boinapally S, Ahn HH, Cheng B, et al. (2021) A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile. Scientific Reports. 11: 7114
Datan E, Minn I, Xu P, et al. (2020) A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia. Iscience. 23: 101536
Duan X, Liu F, Kwon H, et al. (2020) (S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as A Novel PSMA Targeting Scaffold for Prostate Cancer Imaging. Journal of Medicinal Chemistry
Shen CJ, Minn I, Hobbs RF, et al. (2020) Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer. Theranostics. 10: 2888-2896
Kim K, Kwon H, Bařinka C, et al. (2020) Novel β- and γ-amino acid derived inhibitors of prostate-specific membrane antigen. Journal of Medicinal Chemistry
Son SH, Kwon H, Ahn HH, et al. (2019) Design and synthesis of a novel BODIPY-labeled PSMA inhibitor. Bioorganic & Medicinal Chemistry Letters. 126894
Banerjee SR, Kumar V, Lisok A, et al. (2019) Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy. European Journal of Nuclear Medicine and Molecular Imaging
Minn I, Huss DJ, Ahn HH, et al. (2019) Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Science Advances. 5: eaaw5096
Ray Banerjee S, Minn IL, Kumar V, et al. (2019) Preclinical evaluation of Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
See more...